Sample source | TNF production (pg/ml) | Inhibition (%) | |
---|---|---|---|
SFL | SFL – NK | ||
Rheumatoid arthritis (n = 5) | 9,237 ± 4,062 | 2,472 ± 2,472 | 73.2 |
Spondyloarthropathies (n = 6) | 2,680 ± 503 | 1,407 ± 442 | 47.5 |
Crystal-associated arthritis (n = 4) | 3,557 ± 1,402 | 2,478 ± 1,196 | 30.3 |
Total (n = 15) | 5,187 ± 1,735 | 2,059 ± 491 | 60.3a |